BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marcucci F, Rumio C. Glycolysis-induced drug resistance in tumors-A response to danger signals? Neoplasia 2021;23:234-45. [PMID: 33418276 DOI: 10.1016/j.neo.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xi Y, Li T, Xi Y, Zeng X, Miao Y, Guo R, Zhang M, Li B. Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer. Cancer Cell Int 2022;22:271. [PMID: 36050724 DOI: 10.1186/s12935-022-02681-0] [Reference Citation Analysis]
2 Lin H, Wang Y, Wang P, Long F, Wang T. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol Cancer 2022;21:148. [PMID: 35843942 DOI: 10.1186/s12943-022-01620-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, Fu L. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol 2022;15:97. [PMID: 35851420 DOI: 10.1186/s13045-022-01313-4] [Reference Citation Analysis]
4 Oliveira T, Lemos D, Jean L, Kawashima JM, de Azevedo VR, Salustiano EJ, Rumjanek VM, Monteiro RQ. Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells. Front Oncol 2022;12:852985. [PMID: 35719932 DOI: 10.3389/fonc.2022.852985] [Reference Citation Analysis]
5 Rawat SG, Tiwari RK, Jaiswara PK, Gupta VK, Sonker P, Vishvakarma NK, Kumar S, Pathak C, Gautam V, Kumar A. Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism. Apoptosis 2022. [PMID: 35725975 DOI: 10.1007/s10495-022-01741-0] [Reference Citation Analysis]
6 Dong P, Wang F, Chang L, Yue J. Editorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance. Front Cell Dev Biol 2022;10:893868. [DOI: 10.3389/fcell.2022.893868] [Reference Citation Analysis]
7 Cui Q, Liang XL, Wang JQ, Zhang JY, Chen ZS. Therapeutic implication of carbon monoxide in drug resistant cancers. Biochem Pharmacol 2022;:115061. [PMID: 35489394 DOI: 10.1016/j.bcp.2022.115061] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharma V, Letson J, Furuta S. Fibrous stroma: Driver and passenger in cancer development. Sci Signal 2022;15:eabg3449. [PMID: 35258999 DOI: 10.1126/scisignal.abg3449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gao M, Yang Y, Gao Y, Liu T, Guan Q, Zhou T, Shi Y, Hao M, Li Z, Zuo D, Zhang W, Wu Y. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-D-glucose. Chem Biol Interact 2022;:109843. [PMID: 35122754 DOI: 10.1016/j.cbi.2022.109843] [Reference Citation Analysis]
11 Liu XY, Zhang Q, Guo J, Zhang P, Liu H, Tian ZB, Zhang CP, Li XY. The Role of Circular RNAs in the Drug Resistance of Cancers. Front Oncol 2021;11:790589. [PMID: 35070998 DOI: 10.3389/fonc.2021.790589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Reference Citation Analysis]
13 Wu L, Liu J, Li W. Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma. Journal of Dental Sciences 2021. [DOI: 10.1016/j.jds.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Alvarez R, Mandal D, Chittiboina P. Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors. Cells 2021;10:2913. [PMID: 34831136 DOI: 10.3390/cells10112913] [Reference Citation Analysis]
15 Wang M, Chen W, Chen J, Yuan S, Hu J, Han B, Huang Y, Zhou W. Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies. Eur J Med Chem 2021;220:113487. [PMID: 33933752 DOI: 10.1016/j.ejmech.2021.113487] [Reference Citation Analysis]
16 Marcucci F, Rumio C. Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer. Cells 2021;10:872. [PMID: 33921301 DOI: 10.3390/cells10040872] [Reference Citation Analysis]